UnitedHealth sued by shareholders over its reaction to backlash from executive’s killing

    By Jonathan Stempel NEW YORK (Reuters) -UnitedHealth Group was sued on Wednesday for allegedly concealing how backlash from the killing of a top executive was damaging its business, causing its stock to nosedive after the insurer lowered its 2025 outlook. In a proposed class action filed in Manhattan federal court, shareholders said the insurer defrauded…

    Read More

    Gilead announces $11 billion in new investments in US

    (Reuters) -Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research heft, becoming the latest company to announce spending plans in reaction to President Donald Trump’s tariff policy. The new investments, unveiled on Wednesday, will supplement an already planned spending of $21 billion in U.S. manufacturing…

    Read More